çè·åž«
人æ°ã®æ°åã³ãããŠã€ã«ã¹ããŒã¿ã»ãããè±åœã®ç ç©¶è ãæ¹å€

è±åœã®ç ç©¶ã³ã³ãœãŒã·ã¢ã ã¯ã人æ°ã®ãªãŒãã³ãœãŒã¹ ããŒã¿ã»ããã§ãã COVIDx ãäžå¿ã«ãæ°åã³ãããŠã€ã«ã¹ææçæ£è ã®èžéš X ç·åçã®ã³ã³ãã¥ãŒã¿ãŒ ããžã§ã³ ããŒã¹ã®åæã«äœ¿çšããããªãŒãã³ãœãŒã¹ ããŒã¿ã»ããã«å¯Ÿããç§åŠçä¿¡é Œã®çšåºŠã«ã€ããŠæ¹å€ã衚æããŸããã
ç ç©¶è ãã¯ãããŸããŸãªAIãã¬ãŒãã³ã°ã¢ãã«ã§COVIDxããã¹ãããããã¯ãå®éã®èšåºåé¡ã衚ããŠããªãããããã䜿çšããŠåŸãããçµæã¯ãèªåŒµãããŠããããã¢ãã«ã¯çŸå®ã«ãããŸãäžè¬åã§ããªãããšäž»åŒµããŠãããã¯ãŒã«ãããŒã¿ã
èè ãã¯ãŸããCOVIDx ãæ§æããæäŸããŒã¿ã®äžäžèŽã«ã泚ç®ããŠãããå ã®ç»åã¯ããŸããŸãªè§£ååºŠã§æäŸãããæ·±å±€åŠç¿ã¯ãŒã¯ãããŒã«ãã£ãŠãã¬ãŒãã³ã°ã«å¿ èŠãªäžè²«ãããµã€ãºã«èªåçã«åãã©ãŒãããããããã®ããã»ã¹ã«ãã£ãŠæ¬ºççãªã¢ãŒãã£ãã¡ã¯ããå°å ¥ãããå¯èœæ§ãããããšã芳å¯ããŠããŸããããŒã¿ã®èšåºçåŽé¢ã§ã¯ãªããç»åãµã€ãºå€æŽã¢ã«ãŽãªãºã ã«é¢é£ããŠããŸãã
AIããŒã±ãã£ã³ã°æ¥çã¯ã çŽ ãšåŒã°ãã ãªãŒãã³ããŒã¿ã䜿çšããŠèžéš X ç·æ€æ»ã§ æ°åã³ãããŠã€ã«ã¹ææç (COVID-19) ãæ€åºããããã®ãã£ãŒãã©ãŒãã³ã° ãœãªã¥ãŒã·ã§ã³ãéçºããéã®èœãšã穎ããã¯ããªãŒãºå€§åŠã®çç©å»åŠèšç®ç»åã€ã¡ãŒãžã³ã°ããã³ã·ãã¥ã¬ãŒã·ã§ã³ã»ã³ã¿ãŒ (CISTIB) ãšããªãŒãºæè²ç é¢ NHS ãã©ã¹ããå«ãåãåžå ã®ä»ã® XNUMX ã€ã®çµç¹ã®ç ç©¶è ãšã®å ±åç ç©¶ã§ãã
ãã®ç ç©¶ã§ã¯ãä»ã®åŠå®çãªæ £è¡ã®äžã§ãç¹ã«ãCOVIDx ããŒã¿ã»ããã«ããããã©ãã«ã®èª€çšããšãåèŠãšäº€çµ¡ã®é«ããªã¹ã¯ãã«ã€ããŠè©³ãã説æããŠããŸãã ç ç©¶è èªèº«ã XNUMX ã€ã®å®è¡å¯èœãªæ·±å±€åŠç¿ã¢ãã«ã«ããã£ãŠããŒã¿ã»ãããå®è¡ããå®éšãè¡ã£ãçµæãæ¬¡ã®ãããªçµè«ã«éããŸããã ãåé¡é åå šäœã«ããã£ãŠåºãå ±åãããŠããäŸå€çãªããã©ãŒãã³ã¹ã¯èªåŒµãããŠãããã¢ãã«ã®ããã©ãŒãã³ã¹çµæã¯èª€ã£ãŠè¡šçŸãããŠãããã¢ãã«ã¯èšåºçã«çŸå®çãªããŒã¿ã«ããŸãäžè¬åãããŠããŸãããã
XNUMX ã€ã®å¯Ÿç §çãªããŒã¿ã»ããã XNUMX ã€ã«ãŸãšãããã®
ã¬ããŒã* ã¯ããã®åéã«ãããçŸåšã® AI ããŒã¹ã®ææ³ã®å€§éšåããç°çš®ã®ãªãŒãã³ãœãŒã¹ ãªããžããªããã®ãç°çš®ãã®ããŒã¿ã®çµã¿åããã«äŸåããŠããããšãææããŠãããé¡èã«ç°ãªãç¹æ§ãæã€ XNUMX ã€ã®ããŒã¿ã»ãããã(ç ç©¶è ã®èæ ®äºé ïŒããŒã¿ã®å質ãšçš®é¡ã®åçæ§ãäžååã§ãã
COVIDx ããŒã¿ã»ãã㯠ãªãªãŒã¹ 2020 幎 XNUMX æã«ãã«ããã®ãŠã©ãŒã¿ãŒã«ãŒå€§åŠã®ã·ã¹ãã èšèšå·¥åŠéšãäž»å°ããã³ã³ãœãŒã·ã¢ã ã®åãçµã¿ãšããŠãããŒã¿ãæäŸãããŸããã å©çšå¯èœã«ãªã£ã COVID-Net ãªãŒãã³ãœãŒã¹ ã€ãã·ã¢ããã®äžç°ãšããŠã
COVIDx ãæ§æãã 19 ã€ã®ã³ã¬ã¯ã·ã§ã³ã¯æ¬¡ã®ãšããã§ãã ç»åããŒã¿åé ïŒ ãªãŒãã³ãœãŒã¹ ã¢ã³ããªãªãŒã«ã®ç ç©¶è ããã®ã»ããïŒã COVID-19 èžéš X ç·ããŒã¿ã»ãã ã€ãã·ã¢ãã; å®éã®æ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒèžéš X ç·åç ããŒã¿ã»ãã; æ°åã³ãããŠã€ã«ã¹ææçïŒCOVID-19ïŒã®æŸå°ç·æ®åœ± ããŒã¿ããŒã¹; RSNA èºçæ€åºãã£ã¬ã³ãž ããŒã¿ã»ããããã³ãããã¯å±æ©ã®ããã«äœ¿çšãäœåãªããããå€ãã®æ°åã³ãããŠã€ã«ã¹ä»¥åã®ã»ããã®XNUMXã€ã
(RICORD â äžèšãåç § â ã¯ãã®åŸãCOVIDx ã«è¿œå ãããŸããããç ç©¶ã§å¯Ÿè±¡ãšãªãã¢ãã«ã®åŸã«å«ãŸããŠããããããã¹ãããŒã¿ããé€å€ãããŠããããããã«ãããCOVIDx ãããã«å€æ§åããåŸåããããŸããããããç ç©¶èè ãã®äž»ãªäžæºã§ãã)
ç ç©¶è ãã¯ãæ°åã³ãããŠã€ã«ã¹ææçãåå ã§ãããšäž»åŒµããŠããã ãæå€§ãã€æãåºã䜿çšãããŠããã æ°åã³ãããŠã€ã«ã¹ç ç©¶ã«é¢é£ããç§åŠã³ãã¥ããã£å ã®åçš®ã®ããŒã¿ã»ããã§ãããæ§æèŠçŽ ã§ããå€éšããŒã¿ã»ãããã COVIDx ã«ã€ã³ããŒããããããŒã¿ããCOVIDx ããŒã¿ã»ããã® 19 éšæ§æã¹ããŒã (ã€ãŸãããæ£åžžãããèºçãããã) ã«é©åã«æºæ ããŠããªãã COVID XNUMX'ïŒã
ã»ãŒååã§ã...?
ç ç©¶è ãã¯ãç ç©¶æç¹ã§ã®æ°åã³ãããŠã€ã«ã¹ææçã«å¯äžããããŒã¿ã»ããã®åºæãšé©åæ§ã調æ»ãããšãããRSNA ããŒã¿ã®ã誀çšããçºèŠãããã€ãŸããããã¿ã€ãã®ããŒã¿ãå¥ã®ã«ããŽãªãŒã«ãŸãšããããŠãããšç ç©¶è ãã¯äž»åŒµããŠããã
RSNA ãªããžããªã¯ãNIH Chestx-ray ããå ¬éãããŠããèžéš X ç·ããŒã¿ã䜿çšããŸã8 [**]ã¯ãã»ã°ã¡ã³ããŒã·ã§ã³ ã¿ã¹ã¯çšã«èšèšãããŠããããèºæ··æ¿ãããèºæ··æ¿ãªã/æ£åžžã§ãªãããããã³ãæ£åžžããšãã XNUMX ã€ã®ã¯ã©ã¹ã®ç»åãå«ãŸããŠããããèºæ··æ¿ãã®å Žåã«äœ¿çšã§ããå¢çããã¯ã¹ãå«ãŸããŠããŸãã
ãCOVIDx ãžã®ç·šéã§ã¯ããèºæ··æ¿ãã¯ã©ã¹ã®ãã¹ãŠã®èžéš X ç·åçãèºçã¯ã©ã¹ã«å«ãŸããŠããŸããã
äºå®äžããã®è«æã¯ãæ°åã³ãããŠã€ã«ã¹ã®æ¹æ³è«ã¯ãèºçãã®å®çŸ©ãããã¹ãŠã®èºçæ§ã®èºæ··æ¿ããå«ãããã«æ¡åŒµãããšäž»åŒµããŠããã ãã®çµæãæ¯èŒããŒã¿åã®åçã®äŸ¡å€ãïŒããããïŒè ããããŠããŸãã ç ç©¶è ãã¯æ¬¡ã®ããã«è¿°ã¹ãŠããŸãã
[âŠ] COVIDx ããŒã¿ã»ããå ã®èºçã¯ã©ã¹ã«ã¯ãèžæ°Žã浞最ã硬åãèºæ°è «ãè «ç€ãªã©ãä»ã®å€ãã®ç ç¶ãå«ãèžéš X ç·åçãå«ãŸããŠããŸãã å°åºãã¯èºçã®å¯èœæ§ãç€ºãæŸå°ç·åŠçç¹åŸŽã§ãããèšåºèšºæã§ã¯ãããŸããã ãããææžåããã«èºçã®ä»£æ¿ãšããŠçµ±åã䜿çšããããšã¯ãæœåšçã«èª€è§£ãæãå¯èœæ§ããããŸããã

COVIDx ã«é¢é£ãã代æ¿ç ç (COVID-19 以å€)ã åºå ž: https://arxiv.org/ftp/arxiv/papers/2109/2109.08020.pdf
å ±åæžã«ããã°ãRSNA ããåŸãããèºççäŸ 6.13 ä»¶ã®ãã¡æ£ç¢ºã«ã©ãã«ä»ããããã®ã¯ããã 4,305% ã§ãããæ¬ç©ã®èºççäŸã¯ããã 265 ä»¶ã«éããŸããã
ããã«ãæ°åã³ãããŠã€ã«ã¹ã«å«ãŸããèºç以å€ã®çäŸã®å€ãã¯ãä»ã®ç æ°ã®å䜵çããå¿ ãããèºçãšã¯é¢ä¿ã®ãªãäºæ¬¡çãªå»åŠçåé¡ãªã©ã®äœµåçŸæ£ã瀺ããŠããã
æ®éã§ãªã'
ãã®å ±åæžã¯ããã«ãæ°åã³ãããŠã€ã«ã¹ææçã«ãããRSNAãã£ã¬ã³ãžããŒã¿ã»ããã®åœ±é¿ã«ãããããŒã¿ã®çµéšçå®å®æ§ãæªããããããšã瀺åããŠããã ç ç©¶è ãã¯ãCOVIDx ã RSNA ããŒã¿ã®ãæ£åžžãã¯ã©ã¹ãåªå ããããåºç¯ãªããŒã¿ã»ããå ã®ãã¹ãŠã®ãèºæ··æ¿ãªã/æ£åžžã§ã¯ãªããã¯ã©ã¹ãäºå®äžé€å€ããŠããããšã芳å¯ããŠããŸãã çŽã«ã¯æ¬¡ã®ããã«æžãããŠããŸãã
ãããã¯ãæ£åžžããšããã©ãã«å ã§æåŸ ããããã®ãšäžèŽããŠããŸãããèºçã®ã¯ã©ã¹ãæ¡å€§ããèºçé°æ§ã®çäŸã§ã¯ãªããæ£åžžããªèžéšXç·åçã®ã¿ã䜿çšããããšã§ãåé¡äœæ¥ãå€§å¹ ã«ç°¡çŽ åãããŸãã
ããã®æçµçµæã¯ãçã®èšåºåé¡ããé€å€ãããã¿ã¹ã¯ãåæ ããããŒã¿ã»ããã§ããã
äºææ§ã®ãªãããŒã¿æšæºã«ããæœåšçãªãã€ã¢ã¹
ãã®è«æã¯ãæ°åã³ãããŠã€ã«ã¹ææçã«ãããä»ã®å€ãã®ã¿ã€ãã®ãã€ã¢ã¹ãèå¥ããå¯äžããããŒã¿ã®äžéšãå°å ã®èžéšXç·ç»åãšæäººæ£è ã®Xç·ç»åãæ··åããŠããããšãææããããã«ããã®ããŒã¿ãå¯äžã®ãéèŠãªãæ å ±æºã§ããããšã芳å¯ããŠããã COVIDx ã®å°å ç»åã
ãŸããRSNA ããŒã¿ã»ããã®ç»åã®è§£å床㯠1024 à 1024 ã§ãããæäŸãããŠããå¥ã®ããŒã¿ã»ããã®ç»åã®è§£å床㯠299 à 299 ã®ã¿ã§ããæ©æ¢°åŠç¿ã¢ãã«ã¯å©çšå¯èœãªãã¬ãŒãã³ã° ã¹ããŒã¹ (æœåšã¹ããŒã¹) ã«åãããŠåžžã«ç»åã®ãµã€ãºã倿Žããããããã㯠299 à 299 ã®ç»åããã¬ãŒãã³ã° ã¯ãŒã¯ãããŒã§ã¢ããã¹ã±ãŒã«ãããããšãæå³ããŸã (ç çã§ã¯ãªãã¹ã±ãŒãªã³ã° ã¢ã«ãŽãªãºã ã«é¢é£ããã¢ãŒãã£ãã¡ã¯ããçºçããå¯èœæ§ããããŸã)ã倧ããªç»åã¯çž®å°ãããŸããç¹°ãè¿ããŸãããããã«ãããAI ããŒã¹ã®ã³ã³ãã¥ãŒã¿ãŒ ããžã§ã³åæã«å¿ èŠãªå質ãªããŒã¿æšæºãç·©åãããŸãã
ããã«ãCOVIDx ã«åã蟌ãŸãã ActMed ããŒã¿ã«ã¯ãæ°åã³ãããŠã€ã«ã¹ææç (COVID-19) ã®èžéš X ç·åçã«å«ãŸãããåç€ç¶ããŒã«ãŒããå«ãŸããŠããŸããããã¯ãããåºç¯ãªããŒã¿ã»ãããšççŸããå埩çãªç¹åŸŽã§ããããå埩çãªå€ãå€ããšããŠåŠçããå¿ èŠããããŸãã
ããã¯ãéåžžãããŒã¿ãã¯ãªãŒãã³ã°ãããçç¥ããããšã§å¯ŸåŠã§ããçš®é¡ã®åé¡ã§ããããŒã«ãŒã®ç¹°ãè¿ãã¯ããã¬ãŒãã³ã°ã§ãç¹åŸŽããšããŠç»é²ããã«ã¯ååã§ãããããŒã¿ã»ããã®ããåºç¯ãªã¹ããŒã ã§æçšã«äžè¬åã§ããã»ã©é »ç¹ã§ã¯ãªãããã§ãã ã 人工ããŒã«ãŒã®åœ±é¿ãç¡èŠããã¡ã«ããºã ããªããã°ããããã¯æ©æ¢°åŠç¿ã·ã¹ãã ã®æ¹æ³è«ã«ãã£ãŠç çåŠççŸè±¡ãšããŠã¿ãªãããå¯èœæ§ããããŸãã
ãã¬ãŒãã³ã°ãšãã¹ã
ç ç©¶è ãã¯ã1096ã€ã®ã¢ãã«ã«ããã19ã€ã®æ¯èŒããŒã¿ã»ããã«å¯ŸããŠCOVIDxããã¹ãããã远å ã®361ã€ã®ããŒã¿ã»ããã¯ãXNUMXãåœããåéãããXNUMXäººã®æ£è ã®COVID-XNUMXèžéšXç·åçXNUMXæãå«ãRICORDãšã ãã§ãšãã¹ããŒããå ¬éããŒã¿ã»ãã
䜿çšããã XNUMX ã€ã®ã¢ãã«ã¯ãCOVID-Netã ã³ãããã ããã³ ããŒã¯ã³ããããããã XNUMX ã€ã®ã¢ãã«ã¯ãã¹ãŠç³ã¿èŸŒã¿ãã¥ãŒã©ã« ãããã¯ãŒã¯ (CNN) ãæ¡çšããŠããŸãããCoroNet 㯠XNUMX 段éã®ç»ååé¡ããã»ã¹ã§æ§æãããŠããããªãŒããšã³ã³ãŒããŒãåºåã CNN åé¡åšã«æž¡ããŸãã
ãã¹ãã§ã¯ãCOVIDx ããŒã¿ã䜿çšããå Žåã® 86% ã®ç²ŸåºŠãšæ¯èŒããŠãé COVIDx ããŒã¿ã»ããã§ã¯ãã¹ãŠã®ã¢ãã«ã®ããã©ãŒãã³ã¹ããæ¥æ¿ã«äœäžãããããšã瀺ãããŸããã ãã ããããŒã¿ã®ã©ãã«ãééã£ãŠãããã°ã«ãŒãåãééã£ãŠããå Žåããããã¯äºå®äžèª€ã£ãçµæã«ãªããŸãã ç ç©¶è ãã¯ãæ¯èŒå¯èœãªå€éšããŒã¿ã»ããã®çµæã®ç²ŸåºŠãå€§å¹ ã«äœäžããŠããããšã«æ³šç®ããŸããããè«æã§ã¯ãããããçŸå®çã§æ£ããåé¡ãããããŒã¿ãšããŠææ¡ããŠããŸãã
ããã«ããã®è«æã¯æ¬¡ã®ããã«è¿°ã¹ãŠããŸãã
ãCOVIDx æ€æ»ããŒã¿ã®äºæž¬ã«ãã£ãŠçæããã 500 ã® grad-CAM é¡èæ§ãããã®èšåºã¬ãã¥ãŒã§ã¯ãèšåºçã«ç¡é¢ä¿ãªç¹åŸŽã®éèŠæ§ã®åŸåã瀺ãããŸããã ããã«ã¯éåžžãæ°åã³ãããŠã€ã«ã¹ææçã«å žåçãªèºéã®ã³ãŸãæ§äž¡åŽæ··æ¿ã§ã¯ãªãã骚æ§é ãšè»çµç¹ã«çŠç¹ãåœãŠãããšãå«ãŸããŠããŸãããã

ããã¯ã確èªããã COVID-19 çäŸã® X ç·åçã§ãDarkCovidNet ã§ãã¬ãŒãã³ã°ããã COVIDx ããã®äºæž¬ç¢ºçãããã 0.938 ã«å²ãåœãŠãããŠããŸãã
çµè«
ç ç©¶è ãã¯ãæ°åã³ãããŠã€ã«ã¹ã®Xç·ç»åã«é¢é£ãã人å£çµ±èšãèšåºããŒã¿ãæ¬ åŠããŠããããšãæ¹å€ãããããããªããã°å¹Žéœ¢ãªã©ã®ã亀絡å åãã説æããããšã¯äžå¯èœã ãšäž»åŒµããŠããã
圌ãã¯ãŸããCOVIDx ããŒã¿ã»ããã§èŠã€ãã£ãåé¡ã¯ãåæ§ã«ãœãŒã¹ãããä»ã®ããŒã¿ã»ããã«ãé©çšã§ããå¯èœæ§ãããããšã芳å¯ããŠããŸãïŒã€ãŸããé©åãªããŒã¿ ã¢ãŒããã¯ãã£ã忣è£åãããã³æç¢ºãªç¯å²ãªãã§ãæ°åã³ãããŠã€ã«ã¹ä»¥åã®æŸå°ç·ç»åããŒã¿ããŒã¹ãšæè¿ã®æ°åã³ãããŠã€ã«ã¹ã® X ç·ç»åããŒã¿ãæ··åããããšã«ãã£ãŠïŒãã®ã¢ãããŒãã®å¶éã«ã€ããŠèª¬æããŸã)ã
ç ç©¶è ãã¯ãæ°åã³ãããŠã€ã«ã¹ææçã®æ¬ ç¹ãèŠçŽããéã«ããé®®æãªãå°å çšXç·åçãåã£ãŠå«ãŸããŠããããšãšãæ°åã³ãããŠã€ã«ã¹ææçã«ãããã©ãã«ã®èª€çšãšåèŠãšäº€çµ¡ã®é«ããªã¹ã¯ã«ã€ããŠã®èªèã匷調ããæ¬¡ã®ããã«äž»åŒµããŠããã䞊å€ããããã©ãŒãã³ã¹ [æ°åã³ãããŠã€ã«ã¹ã®] åé¡é åå šäœã§åºãå ±åãããŠããåé¡ã¯èªåŒµãããŠãããã¢ãã«ã®ããã©ãŒãã³ã¹çµæã¯èª€ã£ãŠè¡šçŸãããŠãããã¢ãã«ã¯èšåºçã«çŸå®çãªããŒã¿ã«ããŸãäžè¬åãããŠããªãã
ã¬ããŒãã¯æ¬¡ã®ããã«çµè«ä»ããŠããŸãã
ãå©çšå¯èœãªç é¢ããŒã¿ã®æ¬ åŠãšãåé¡é åå šäœã«ãããäžé©åãªã¢ãã«è©äŸ¡ãçžãŸã£ãŠããªãŒãã³ãœãŒã¹ ããŒã¿ã®äœ¿çšãç ç©¶ã³ãã¥ããã£ã«èª€è§£ãäžããããšãå¯èœã«ããŠããŸãã ã¢ãã«ã®ããã©ãŒãã³ã¹ææšãæ°Žå¢ãããŠçºè¡šãç¶ããããšã¯ãç¹ã«ç æ°ãå ¬å ±ã®é¢å¿ãé«ãå Žåãå»ç蚺æã«ããã AI ç ç©¶ã®ä¿¡é Œæ§ãæãªããªã¹ã¯ããããŸãã ãã®ãããªããšãèµ·ãããªãããã«ããããã«ã¯ããã®åéã®ç ç©¶ã®è³ªãåäžãããå¿ èŠããããŸããããã¯ããŒã¿ããå§ããªããã°ãªããŸãããã
*ãã®ç ç©¶ã®ç ç©¶è
ãã¡ã¯ãæ°ããè«æã®ããŒã¿ããã¡ã€ã«ãã³ãŒããäœæãããšäž»åŒµããŠããŸããã ãªã³ã©ã€ã³ã§å©çšå¯èœãã¢ã¯ã»ã¹ããã«ã¯ãã°ã€ã³ãå¿
èŠã§ããããã®èšäºã®å·çæç¹ã§ã¯ããã¡ã€ã«ãžã®äžè¬å
¬éã¢ã¯ã»ã¹ã¯å©çšã§ããŸããã
** ChestX-ray8: ç
é¢èŠæš¡ã®èžéš X ç·ããŒã¿ããŒã¹ãšãäžè¬çãªèžéšçŸæ£ã®åŒ±ãæåž«ã«ããåé¡ãšäœçœ®ç¹å®ã«é¢ãããã³ãããŒã¯ â https://arxiv.org/pdf/1705.02315.pdf